Viewing Study NCT07164534


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-06-06 @ 7:53 AM
Study NCT ID: NCT07164534
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2025-09-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.
Sponsor: Tata Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Cervical Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cervix cancer View
None radiation-related adverse effects View
None radiation View
None sodium-copper-chlorophyllin View